These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 17156673

  • 1. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
    Lu XY, Ye S, Wang Y, Guo L, Chen XX, Fan W, Wang XD, Gu YY, Bao CD, Liu Q.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2462-6. PubMed ID: 17156673
    [Abstract] [Full Text] [Related]

  • 2. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T, Hirata D, Onda K, Nara H, Minota S.
    J Rheumatol; 2005 Jan 19; 32(1):34-9. PubMed ID: 15630721
    [Abstract] [Full Text] [Related]

  • 3. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, Sánchez-Guerrero J.
    PLoS One; 2008 Oct 06; 3(10):e3347. PubMed ID: 18836530
    [Abstract] [Full Text] [Related]

  • 4. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Oct 06; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 5. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
    Arinuma Y, Yanagida T, Hirohata S.
    Arthritis Rheum; 2008 Apr 06; 58(4):1130-5. PubMed ID: 18383393
    [Abstract] [Full Text] [Related]

  • 6. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun 06; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 7. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H, Atisha-Fregoso Y, Núñez-Alvarez CA, Llorente L, Sánchez-Guerrero J.
    J Rheumatol; 2012 Mar 06; 39(3):504-9. PubMed ID: 22247358
    [Abstract] [Full Text] [Related]

  • 8. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Kimura A, Kanoh Y, Sakurai T, Koumura A, Yamada M, Hayashi Y, Tanaka Y, Hozumi I, Takemura M, Seishima M, Inuzuka T.
    Neurology; 2010 Apr 27; 74(17):1372-9. PubMed ID: 20421581
    [Abstract] [Full Text] [Related]

  • 9. Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations.
    Silva LM, Garcia AB, Donadi EA.
    J Neurol; 2002 Aug 27; 249(8):1048-54. PubMed ID: 12195452
    [Abstract] [Full Text] [Related]

  • 10. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.
    Arthritis Rheum; 2009 Jul 27; 60(7):2094-101. PubMed ID: 19565516
    [Abstract] [Full Text] [Related]

  • 11. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases.
    Kang EH, Shen GQ, Morris R, Metzger A, Lee EY, Lee YJ, Lee EB, Song YW.
    Lupus; 2008 Jan 27; 17(1):21-5. PubMed ID: 18089679
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Llorente L, Sánchez-Guerrero J.
    Arthritis Rheum; 2007 Apr 27; 56(4):1242-50. PubMed ID: 17393453
    [Abstract] [Full Text] [Related]

  • 13. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L, Dehoorne J, Joos R, Hendrickx G, Houssiau F, Elewaut D.
    Ann Rheum Dis; 2009 Mar 27; 68(3):412-5. PubMed ID: 18930995
    [Abstract] [Full Text] [Related]

  • 14. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
    Isshi K, Hirohata S.
    Arthritis Rheum; 1998 Oct 27; 41(10):1819-27. PubMed ID: 9778223
    [Abstract] [Full Text] [Related]

  • 15. Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach.
    Lefranc D, Launay D, Dubucquoi S, de Seze J, Dussart P, Vermersch M, Hachulla E, Hatron PY, Vermersch P, Mouthon L, Prin L.
    Arthritis Rheum; 2007 Oct 27; 56(10):3420-32. PubMed ID: 17907141
    [Abstract] [Full Text] [Related]

  • 16. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H, Atisha-Fregoso Y, Nuñez-Alvarez CA, Llorente L.
    Lupus; 2016 Apr 27; 25(4):364-9. PubMed ID: 26466614
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y, Mader S, Jeganathan V, Arinuma Y, Shimizu Y, Kato M, Oku K, Minami A, Shimizu C, Yasuda S, Atsumi T.
    Int J Rheum Dis; 2019 Mar 27; 22(3):443-448. PubMed ID: 30358102
    [Abstract] [Full Text] [Related]

  • 18. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
    Ikenouchi-Sugita A, Yoshimura R, Okamoto T, Umene-Nakano W, Ueda N, Hori H, Katsuki A, Saito K, Tanaka Y, Nakamura J.
    World J Biol Psychiatry; 2010 Mar 27; 11(2):121-8. PubMed ID: 20109107
    [Abstract] [Full Text] [Related]

  • 19. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
    Bosma GP, Rood MJ, Zwinderman AH, Huizinga TW, van Buchem MA.
    Arthritis Rheum; 2000 Jan 27; 43(1):48-54. PubMed ID: 10643699
    [Abstract] [Full Text] [Related]

  • 20. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Ho RC, Thiaghu C, Ong H, Lu Y, Ho CS, Tam WW, Zhang MW.
    Autoimmun Rev; 2016 Feb 27; 15(2):124-38. PubMed ID: 26497108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.